Data / Form D filings / Novan, Inc.
Novan, Inc.: Form D filings
Novan, Inc., a biotechnology company in Durham, NC, filed 12 Form D notices with the SEC between 2009 and 2015. The latest, on December 30, 2015, reports $32.8 million sold of a $32.8 million offering to 172 investors.
Find out what Novan, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4222 EMPEROR BLVD, SUITE 200, Durham, NC, 27703
- Phone
- (919) 485-8080
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1467154
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2015 | Amendment | $32,840,304 | $32,840,304 | $0 | 172 | Dec 1, 2015 | sec.gov |
| Dec 16, 2015 | New notice | $31,000,000 | $30,409,735 | $590,265 | 146 | Dec 1, 2015 | sec.gov |
| Mar 30, 2015 | Amendment | $50,000,008 | $50,000,008 | $0 | 91 | Aug 14, 2014 | sec.gov |
| Aug 29, 2014 | New notice | $25,000,000 | $10,325,093 | $14,674,907 | 61 | Aug 14, 2014 | sec.gov |
| Mar 10, 2014 | New notice | $3,502,125 | $3,502,125 | $0 | 36 | Feb 24, 2014 | sec.gov |
| Feb 28, 2013 | Amendment | $11,000,000 | $11,000,000 | $0 | 50 | Apr 30, 2012 | sec.gov |
| May 31, 2012 | New notice | $5,170,000 | $5,170,000 | $0 | 17 | Apr 30, 2012 | sec.gov |
| Sep 29, 2011 | Amendment | $5,999,989 | $5,999,968 | $21 | 12 | Nov 3, 2010 | sec.gov |
| Aug 29, 2011 | Amendment | $5,999,989 | $5,599,986 | $400,003 | 11 | Nov 3, 2010 | sec.gov |
| Jan 18, 2011 | Amendment | $3,999,992 | $3,999,992 | $0 | 9 | Nov 3, 2010 | sec.gov |
| Nov 18, 2010 | New notice | $3,999,992 | $3,049,994 | $949,998 | 9 | Nov 3, 2010 | sec.gov |
| Jul 2, 2009 | New notice | $2,000,000 | $2,000,000 | $0 | 5 | Jul 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Schoenfisch | Director | |
| G. Kelly Martin | Director | |
| Sean Kelly Murphy | Director | |
| F Neal Hunter | Director | |
| W. Kent Geer | Director | |
| John W Palmour | Director | |
| Richard Kelly Peterson | Executive Officer | |
| Robert A Ingram | Director | |
| Nathan Stasko | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Dec 28, 2015 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Novan, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.